Loading…

Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study

A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was des...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiology and infection 2023-07, Vol.151, p.e136, Article e136
Main Authors: van den Berg, Oda E., Stanoeva, Kamelia R., Zonneveld, Rens, Hoek-van Deursen, Denise, van der Klis, Fiona R., van de Kassteele, Jan, Franz, Eelco, Opsteegh, Marieke, Friesema, Ingrid H. M., Kortbeek, Laetitia M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943
cites cdi_FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943
container_end_page
container_issue
container_start_page e136
container_title Epidemiology and infection
container_volume 151
creator van den Berg, Oda E.
Stanoeva, Kamelia R.
Zonneveld, Rens
Hoek-van Deursen, Denise
van der Klis, Fiona R.
van de Kassteele, Jan
Franz, Eelco
Opsteegh, Marieke
Friesema, Ingrid H. M.
Kortbeek, Laetitia M.
description A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9–1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.
doi_str_mv 10.1017/S095026882300122X
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10540174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S095026882300122X</cupid><sourcerecordid>2850996930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943</originalsourceid><addsrcrecordid>eNp1kctuFDEQRS1ERCaBD2CDLLFh06T86LbNBkURgUgRLBIkdpbHj4lDd3uwuyPyA3w3nswkvMTGLrlO3XLdQug5gdcEiDi6ANUC7aSkDIBQ-uURWhDeqYZzUI_RYpNuNvl9dFDKNQAoKsUTtM9EC6wDuUA_LnxO6-xvTO9H63EK-DJ9T-velMHgVRpdjNiMDptSko1m8g7nWL7iYOyUcsEhZRzH4O0U01gjPF15_NHXM_e1rrypDzE7bHMqpSlbzvR4NLugTLO7fYr2gumLf7a7D9Hn03eXJx-a80_vz06OzxvLBZ0aS0RnhLU2gCOuVSC5FE4ADd2Sekcs7ZRglHEL3DNnWyU7ylX1RzkXFGeH6O1Wdz0vB--sH6dser3OcTD5VicT9Z-ZMV7pVbrRBFpeLd8ovNop5PRt9mXSQyzW93VYn-aiqWyJrJa3sqIv_0Kv05zrzHcUKNUpBpUiW-rOoezDw28I6M2a9T9rrjUvfh_joeJ-rxVgO1EzLHN0K_-r9_9lfwIORLUH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2850996930</pqid></control><display><type>article</type><title>Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study</title><source>Cambridge Journals Online</source><source>PubMed Central</source><creator>van den Berg, Oda E. ; Stanoeva, Kamelia R. ; Zonneveld, Rens ; Hoek-van Deursen, Denise ; van der Klis, Fiona R. ; van de Kassteele, Jan ; Franz, Eelco ; Opsteegh, Marieke ; Friesema, Ingrid H. M. ; Kortbeek, Laetitia M.</creator><creatorcontrib>van den Berg, Oda E. ; Stanoeva, Kamelia R. ; Zonneveld, Rens ; Hoek-van Deursen, Denise ; van der Klis, Fiona R. ; van de Kassteele, Jan ; Franz, Eelco ; Opsteegh, Marieke ; Friesema, Ingrid H. M. ; Kortbeek, Laetitia M.</creatorcontrib><description>A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9–1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.</description><identifier>ISSN: 0950-2688</identifier><identifier>ISSN: 1469-4409</identifier><identifier>EISSN: 1469-4409</identifier><identifier>DOI: 10.1017/S095026882300122X</identifier><identifier>PMID: 37503608</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Age groups ; Antibodies ; Antibodies, Protozoan ; Antigens ; Child ; Cross-Sectional Studies ; Cysts ; Gender ; Humans ; Infections ; Netherlands - epidemiology ; Original Paper ; Population ; Protozoa ; Public health ; Questionnaires ; Regression analysis ; Risk Factors ; Seroepidemiologic Studies ; Serology ; Toxoplasma ; Toxoplasma gondii ; Toxoplasmosis ; Toxoplasmosis - epidemiology ; Womens health</subject><ispartof>Epidemiology and infection, 2023-07, Vol.151, p.e136, Article e136</ispartof><rights>The Author(s), 2023. Published by Cambridge University Press</rights><rights>The Author(s), 2023. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023 2023 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943</citedby><cites>FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943</cites><orcidid>0000-0002-9518-5102 ; 0000-0001-9943-0518 ; 0000-0002-6142-8145</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540174/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S095026882300122X/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,72832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37503608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van den Berg, Oda E.</creatorcontrib><creatorcontrib>Stanoeva, Kamelia R.</creatorcontrib><creatorcontrib>Zonneveld, Rens</creatorcontrib><creatorcontrib>Hoek-van Deursen, Denise</creatorcontrib><creatorcontrib>van der Klis, Fiona R.</creatorcontrib><creatorcontrib>van de Kassteele, Jan</creatorcontrib><creatorcontrib>Franz, Eelco</creatorcontrib><creatorcontrib>Opsteegh, Marieke</creatorcontrib><creatorcontrib>Friesema, Ingrid H. M.</creatorcontrib><creatorcontrib>Kortbeek, Laetitia M.</creatorcontrib><title>Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study</title><title>Epidemiology and infection</title><addtitle>Epidemiol. Infect</addtitle><description>A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9–1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.</description><subject>Age groups</subject><subject>Antibodies</subject><subject>Antibodies, Protozoan</subject><subject>Antigens</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Cysts</subject><subject>Gender</subject><subject>Humans</subject><subject>Infections</subject><subject>Netherlands - epidemiology</subject><subject>Original Paper</subject><subject>Population</subject><subject>Protozoa</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Seroepidemiologic Studies</subject><subject>Serology</subject><subject>Toxoplasma</subject><subject>Toxoplasma gondii</subject><subject>Toxoplasmosis</subject><subject>Toxoplasmosis - epidemiology</subject><subject>Womens health</subject><issn>0950-2688</issn><issn>1469-4409</issn><issn>1469-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kctuFDEQRS1ERCaBD2CDLLFh06T86LbNBkURgUgRLBIkdpbHj4lDd3uwuyPyA3w3nswkvMTGLrlO3XLdQug5gdcEiDi6ANUC7aSkDIBQ-uURWhDeqYZzUI_RYpNuNvl9dFDKNQAoKsUTtM9EC6wDuUA_LnxO6-xvTO9H63EK-DJ9T-velMHgVRpdjNiMDptSko1m8g7nWL7iYOyUcsEhZRzH4O0U01gjPF15_NHXM_e1rrypDzE7bHMqpSlbzvR4NLugTLO7fYr2gumLf7a7D9Hn03eXJx-a80_vz06OzxvLBZ0aS0RnhLU2gCOuVSC5FE4ADd2Sekcs7ZRglHEL3DNnWyU7ylX1RzkXFGeH6O1Wdz0vB--sH6dser3OcTD5VicT9Z-ZMV7pVbrRBFpeLd8ovNop5PRt9mXSQyzW93VYn-aiqWyJrJa3sqIv_0Kv05zrzHcUKNUpBpUiW-rOoezDw28I6M2a9T9rrjUvfh_joeJ-rxVgO1EzLHN0K_-r9_9lfwIORLUH</recordid><startdate>20230728</startdate><enddate>20230728</enddate><creator>van den Berg, Oda E.</creator><creator>Stanoeva, Kamelia R.</creator><creator>Zonneveld, Rens</creator><creator>Hoek-van Deursen, Denise</creator><creator>van der Klis, Fiona R.</creator><creator>van de Kassteele, Jan</creator><creator>Franz, Eelco</creator><creator>Opsteegh, Marieke</creator><creator>Friesema, Ingrid H. M.</creator><creator>Kortbeek, Laetitia M.</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9518-5102</orcidid><orcidid>https://orcid.org/0000-0001-9943-0518</orcidid><orcidid>https://orcid.org/0000-0002-6142-8145</orcidid></search><sort><creationdate>20230728</creationdate><title>Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study</title><author>van den Berg, Oda E. ; Stanoeva, Kamelia R. ; Zonneveld, Rens ; Hoek-van Deursen, Denise ; van der Klis, Fiona R. ; van de Kassteele, Jan ; Franz, Eelco ; Opsteegh, Marieke ; Friesema, Ingrid H. M. ; Kortbeek, Laetitia M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age groups</topic><topic>Antibodies</topic><topic>Antibodies, Protozoan</topic><topic>Antigens</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Cysts</topic><topic>Gender</topic><topic>Humans</topic><topic>Infections</topic><topic>Netherlands - epidemiology</topic><topic>Original Paper</topic><topic>Population</topic><topic>Protozoa</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Seroepidemiologic Studies</topic><topic>Serology</topic><topic>Toxoplasma</topic><topic>Toxoplasma gondii</topic><topic>Toxoplasmosis</topic><topic>Toxoplasmosis - epidemiology</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van den Berg, Oda E.</creatorcontrib><creatorcontrib>Stanoeva, Kamelia R.</creatorcontrib><creatorcontrib>Zonneveld, Rens</creatorcontrib><creatorcontrib>Hoek-van Deursen, Denise</creatorcontrib><creatorcontrib>van der Klis, Fiona R.</creatorcontrib><creatorcontrib>van de Kassteele, Jan</creatorcontrib><creatorcontrib>Franz, Eelco</creatorcontrib><creatorcontrib>Opsteegh, Marieke</creatorcontrib><creatorcontrib>Friesema, Ingrid H. M.</creatorcontrib><creatorcontrib>Kortbeek, Laetitia M.</creatorcontrib><collection>Cambridge Journals Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Epidemiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van den Berg, Oda E.</au><au>Stanoeva, Kamelia R.</au><au>Zonneveld, Rens</au><au>Hoek-van Deursen, Denise</au><au>van der Klis, Fiona R.</au><au>van de Kassteele, Jan</au><au>Franz, Eelco</au><au>Opsteegh, Marieke</au><au>Friesema, Ingrid H. M.</au><au>Kortbeek, Laetitia M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study</atitle><jtitle>Epidemiology and infection</jtitle><addtitle>Epidemiol. Infect</addtitle><date>2023-07-28</date><risdate>2023</risdate><volume>151</volume><spage>e136</spage><pages>e136-</pages><artnum>e136</artnum><issn>0950-2688</issn><issn>1469-4409</issn><eissn>1469-4409</eissn><abstract>A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9–1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>37503608</pmid><doi>10.1017/S095026882300122X</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9518-5102</orcidid><orcidid>https://orcid.org/0000-0001-9943-0518</orcidid><orcidid>https://orcid.org/0000-0002-6142-8145</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-2688
ispartof Epidemiology and infection, 2023-07, Vol.151, p.e136, Article e136
issn 0950-2688
1469-4409
1469-4409
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10540174
source Cambridge Journals Online; PubMed Central
subjects Age groups
Antibodies
Antibodies, Protozoan
Antigens
Child
Cross-Sectional Studies
Cysts
Gender
Humans
Infections
Netherlands - epidemiology
Original Paper
Population
Protozoa
Public health
Questionnaires
Regression analysis
Risk Factors
Seroepidemiologic Studies
Serology
Toxoplasma
Toxoplasma gondii
Toxoplasmosis
Toxoplasmosis - epidemiology
Womens health
title Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroprevalence%20of%20Toxoplasma%20gondii%20and%20associated%20risk%20factors%20for%20infection%20in%20the%20Netherlands:%20third%20cross-sectional%20national%20study&rft.jtitle=Epidemiology%20and%20infection&rft.au=van%20den%20Berg,%20Oda%20E.&rft.date=2023-07-28&rft.volume=151&rft.spage=e136&rft.pages=e136-&rft.artnum=e136&rft.issn=0950-2688&rft.eissn=1469-4409&rft_id=info:doi/10.1017/S095026882300122X&rft_dat=%3Cproquest_pubme%3E2850996930%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-c176a7cccf0d1d5908487d702f6b2ed1c26973234c04e3dc59862498239ddf943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2850996930&rft_id=info:pmid/37503608&rft_cupid=10_1017_S095026882300122X&rfr_iscdi=true